Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05431894 · ClinicalTrials.gov registry record · NA
Behavioral and Recovery Support for 30 Day Post-Discharge Care
A NA study of Cardiovascular Diseases, sponsored by Laguna Health.
- Completed
- Registry status
- NA
- Development phase
- 408
- Enrollment target
- 1
- Study location
NCT05431894: Completed NA study of Cardiovascular Diseases, sponsored by Laguna Health.
NCT05431894 is a NA study of Cardiovascular Diseases that has completed, run by Laguna Health. The registered enrollment target is 408 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05431894, a NA study of Cardiovascular Diseases, has completed, sponsored by Laguna Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 408 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will provide behavioral and mental health support to a select group of participants to supplement the hospital-provided discharge and recovery plans, based on clinical guidance and dedicated post-hospitalization behavioral protocols, with the goals of reducing readmission rates and costs.
Primary Outcome
Unplanned All-Cause 30 Day Readmission Rate
Conditions Studied
Interventions
- BEHAVIORAL Laguna Coach Intervention Group
Study Locations (1)
Illinois
- NorthShore University HealthSystem - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2021-02-18 |
| Est. Completion | 2022-06-13 |
| Phase | NA |
What the finished NCT05431894 record still lists
NCT05431894 is an interventional study that assigns participants to a tested intervention. The registered 408 participants enrollment target is mid-sized for trials with a published cap, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Laguna Coach Intervention Group is the first listed.
NCT05431894 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05431894 about?
NCT05431894 is a clinical study titled "Behavioral and Recovery Support for 30 Day Post-Discharge Care". This study will provide behavioral and mental health support to a select group of participants to supplement the hospital-provided discharge and recovery plans, based on clinical guidance and dedicated post-hospitalization behavioral protocols, with the goals of reducing readmission rates and costs.
What is the current status of trial NCT05431894?
This trial is currently completed. It is a NA study. The enrollment target is 408 participants. The study started on 2021-02-18. Estimated completion is 2022-06-13.
What conditions does trial NCT05431894 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT05431894?
The interventions under investigation include: Laguna Coach Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT05431894?
This trial is sponsored by Laguna Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05431894 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05431894's enrollment target sits among peer trials
408 104th of 300 higher than 197 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04835428 · 408 participants · NA
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- NCT05836324 · 408 participants · Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
- NCT05863195 · 408 participants · Phase 3
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- NCT06612268 · 408 participants · Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI